Showing results (21-30 of 135) with videos related to

Sort By:
Pageof 14
Journal of Molecular Medicine (Berlin, Germany)|January 11, 2007
Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levelsStephanie Schäfer, Frank-Gerald Pajonk, Gerd Multhaup, et al.
Neurobiology of Aging|January 12, 2007
Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's diseaseOliver Wirths, Henning Breyhan, Stephanie Schäfer, et al.
Journal of the American Geriatrics Society|June 6, 2025
Transitional Care Management in Persons With Dementia After Heart Failure Hospitalization and Skilled Nursing Facility CareThomas A Bayer, Hiren Varma, Peter A Hollmann, et al.
Journal of Alzheimer'S Disease : JAD|September 11, 2013
Shotgun brain proteomics reveals early molecular signature in presymptomatic mouse model of Alzheimer's diseaseHongqian Yang, Jessica L Wittnam, Roman A Zubarev, et al.
Aging Cell|April 11, 2018
SUMO1-conjugation is altered during normal aging but not by increased amyloid burdenTrayana Stankova, Lars Piepkorn, Thomas A Bayer, et al.
Acta Neuropathologica|March 8, 2006
Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's diseaseOliver Wirths, Joachim Weis, Jacek Szczygielski, et al.
Journal of Alzheimer'S Disease : JAD|March 14, 2013
Oligomeric pyroglutamate amyloid-β is present in microglia and a subfraction of vessels in patients with Alzheimer's disease: implications for immunotherapyOliver Wirths, Antje Hillmann, Laurent Pradier, et al.
Neuro-Degenerative Diseases|March 7, 2008
Intraneuronal beta-amyloid is a major risk factor--novel evidence from the APP/PS1KI mouse modelThomas A Bayer, Henning Breyhan, Kailai Duan, et al.
Brain Research|April 13, 2007
Altered cholesterol metabolism in APP695-transfected neuroblastoma cellsOliver Wirths, Karin M Thelen, Dieter Lütjohann, et al.
Pageof 14